Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by boazklinghornon Jun 05, 2023 1:14pm
79 Views
Post# 35480706

RE:RE:The reality

RE:RE:The reality "CZO is the only producer of natural avenanthramide at scale in the world with 58% gross margin last fiscal year. Where does boazklinghorn think those using CZO's avenanthramide are going to get it from if not for CZO? "

Good point Prof. So why cant Gilles ever sell more product?  If we are the only game in town where are the other buyers? Gilles has never grown the business beyond selling to one customer, Symrise. 
Nice work if you can get it. Make two things sell them to one buyer collect a big paycheck. Never sign any other deals never increase shareholder value laugh all the way to the bank. 
 


<< Previous
Bullboard Posts
Next >>